Latest news with #PharmEasy


Hans India
16-05-2025
- Business
- Hans India
API Holdings Limited Supercharges its Digital Health Technology Stack with IBM Instana
API Holdings Limited ('API'), among India's largest digital healthcare platform and the parent company of the entities owning leading brands such as Pharm Easy, Thyrocare, and Retailio, today announced their collaboration with IBM to harness the power of AI-driven automated observability to proactively manage their application stack using IBM Instana. This has empowered API to deliver seamless healthcare services to customers while accelerating time-to-market for new services. With IBM Instana, API has deployed full-stack, real-time observability across its complex microservices architecture, ensuring rapid incident detection, accelerated root cause analysis, and continuous performance optimization for its consumer and enterprise applications. This has resulted in up to 30% reduction in Mean Time to Resolution (MTTR) for issues, improved developer productivity, and created a scalable observability foundation for future growth of their application landscape. 'IBM Instana has become our command center for incident management - intuitive, developer-friendly, and powerful. From real-time alerts to precise root cause analysis, it plays a central role in maintaining our application uptime ultimately enhancing customer trust. A high confidence on application monitoring and uptime has made more time for our Tech teams to innovate and perform higher value work like rapidly launching new services on its platforms,' said Vivek Kumar Singh, Vice President, Engineering, API. IBM Instana is currently deployed across three major businesses owned by API - Pharm Easy, Thyrocare, and Retailio to monitor a diverse range of mission-critical applications. Its seamless integration with automation systems and collaboration tools ensures real-time alerts through chat platforms and rapid incident resolution via virtual meeting platforms. 'Succeeding in today's competitive digital healthcare sector demands always-on performance and instant incident resolution. Our work with API exemplifies how having insights-driven visibility of application and infrastructure environments can enable healthcare businesses drive productivity, innovate at pace, stay resilient, and continually deliver value to customers,' said Viswanath Ramaswamy, Vice President, Technology, IBM India & South Asia.


Time of India
12-05-2025
- Business
- Time of India
Built a Rs 5,000 cr empire. But Dr A Velumani 'runs away fast' from these kind of people
Tired of too many ads? Remove Ads About Dr A. Velumani In today's fast-paced, high-pressure world, emotional intelligence is becoming just as crucial as professional skills. And when a man like Dr A. Velumani , the founder of Thyrocare and a self-made billionaire , shares his thoughts on human behaviour, it's worth paying attention. In a recent tweet, the Rs 5,000 crore entrepreneur offered a refreshingly honest take on the kinds of people he encounters and why he gravitates toward some — and instinctively distances himself from A. Velumani, known for building Thyrocare from scratch and scaling it into a Rs 5,000 crore enterprise, isn't just a business mind, he's a keen observer of people. In a tweet that reads more like a life lesson than a status update, Velumani reflected on the range of personalities he's come across in recent interactions. From youth to elders, rich to poor, he emphasised that his conversations aren't motivated by business interests or socialising, but by a curiosity to understand how people identified two broad emotional spectrums: those who show zero emotion and those who are highly emotional. Within the emotional group, he further broke it down into two stark opposites. On one side are the optimists- people who radiate happiness, express gratitude, keep smiling, and uplift those around them. Velumani admits he enjoys spending time with such individuals. But on the other end are the constant complainers- those who grumble, blame, hurt others with negativity, and stay withdrawn. Of them, he writes simply: "I wish to runaway fast."Dr. A Velumani was born in a small village near Coimbatore to a landless farmer, he grew up in a humble household where his mother sold buffalo milk to make ends meet. From these modest beginnings, he went on to earn a PhD in Thyroid Biochemistry while working at BARC . But his real leap came when he founded Thyrocare, a diagnostic empire built from 2021, Dr. Velumani grabbed national attention when he sold a majority stake in Thyrocare to PharmEasy for a staggering Rs 4,500 crore. What made the deal remarkable wasn't just the number, but how he got there. Owning over 66% of the company at the time, Velumani had built his stake the old-fashioned way, through years of disciplined reinvestment, without relying on loans, investors, or headline-making fundraising. It was a rare feat in India's startup landscape, underscoring his belief in bootstrapped growth and long-term value creation.


Time of India
05-05-2025
- Business
- Time of India
PharmEasy's new TVC asks one to take it easy
HighlightsPharmEasy, a leading digital healthcare platform in India, has launched a new campaign focused on increasing awareness and adoption of its diagnostic services, emphasizing its promise of 'on-time or free' services. The campaign features the return of the brand's signature jingle and introduces relatable characters that highlight common consumer frustrations with delays in diagnostic testing, showcasing the company's commitment to punctuality. Siddharth Shah, the managing director and chief executive officer of API Holdings, emphasised that the campaign reflects the company's journey towards simplifying healthcare and making it accessible and dependable for all Indians. PharmEasy , one of India's digital healthcare platforms, has launched a new campaign. With its signature brand jingle— 'PharmEasy, PharmEasy…Take It Easy'—making a comeback, the campaign aims to build awareness and adoption of PharmEasy's diagnostic services , anchored around the powerful promise: ' on-time or free '. Created by independent creative agency, BusyPeople, led by Garima Khandelwal, the campaign brings back the beloved dancing uncles, tapping into two relatable personas—one obsessed with food and the other with punctuality. These characters humorously highlight the exact issues consumers face: waiting to break a fast or a disrupted morning routine due to delayed sample collections. In a category plagued by delays, missed appointments, long and uncomfortable waits, often on an empty stomach, PharmEasy's new ad showcases how the platform transforms the diagnostic business. Because when it comes to lab tests , punctuality isn't a luxury, it's a necessity. With its new campaign, PharmEasy directly addresses this customer pain point. 'We kept the tonality of the brand at the centre while working on the campaign, sharply landing the offering, keeping it relevant, relatable and entertaining," shared Garima Khandelwal, founder and creative director, BusyPeople. 'This campaign is a reflection of how far we've come in our journey of simplifying healthcare and making it truly accessible and dependable for every Indian. Diagnostic testing is a sensitive experience - fasting is tough, but waiting shouldn't be. Our promise is simple: you pick the time slot, we'll be there. If we're late, your test is on us,' said Siddharth Shah , managing director and chief executive officer, API Holdings. Gaurav Verma, chief business officer, PharmEasy (API Holdings) said, 'When you are fasting and waiting for a blood test to be done, every minute feels like an hour. We built this feature from a deep understanding of that frustration. You've done your part—waking up early, skipping breakfast. The least we can do is show up on time. That's our way of saying we care." At the heart of the campaign is the return of the iconic jingle inspired by the track 'Urvashi Urvashi'. The campaign reaffirms PharmEasy's commitment to making healthcare simpler, faster, and easier—one lab test at a time. Watch the videos here: